Richtlijnen

Klik HIER voor de richtlijn 'Large granular lymphocyte leukemia' van de HOVON CLL werkgroep.   

Literatuur

  1. Koskela HL, Eldfors S, Ellonen P et al. Somatic STAT3 mutations in large granular lymphocytic leukemia. N Engl J Med. 2012 May 17;366(20):1905-13
  2. Lamy T, Loughran TP Jr. How I treat LGL leukemia. Blood. 2011 Mar 10;117(10):2764-74
  3. Lamy T, Moignet A, Loughran TP Jr. LGL leukemia: from pathogenesis to treatment. Blood. 2017 Mar 2;129(9):1082-1094
  4. NCCN Guidelines version 2.2015 T-cell large granular lymphocytic leukemia
  5. Sanikommu SR, Clemente MJ, Chomczynski P et al. Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL). Leuk Lymphoma. 2018 Feb;59(2):416-422
  6. Swerdlow SH, Campo E, Harris NL et al. WHO Classification of tumours of haematopoietic and lymphoid tissues, revised 4th edition. World Health Organization; 2017
  7. Sandberg Y et al. Large granular lymphocyte (LGL) leukemie / grootkorrelige lymfocytenleukemie: richtlijnen voor diagnostiek en behandeling. NTVH oktober 2019; 16:349-356
  8. Cheon H et al. Advances in the diagnosis and treatment of large granular lymphocytic leukemia. Curr Hematol Malig Rep. 2020 Apr; 15(2):103-112. doi: 10.1007/s11899-020-00565-6

 

Ga terug naar de LGL homepage of lees meer over LGL:

Ga terug naar de algemene homepage Behandelprotocollen.